MEDIVIR, INTERIM REPORT, 1 January 30 September 2005 (Herpes)
MEDIVIR, INTERIM REPORT, 1 January 30 September 2005 Biotech Intelligence (press release), France - 6 hours ago Phase II study data on the labial herpes (cold sores) indication demonstrates with early the rights to MIV-150 for topical usage in a vaginal microbicide in Sexual health & women The Appalachian Online - Oct 20, 2005 Vaginal discharge test is free to detect trichinosis, yeast and bacterial vaginosis. Herpes test are available when visible sores are present. HEALTH CALENDAR Kansas.com, KS - Oct 23, 2005 fibromyalgia, rheumatoid arthritis, dry eye, irritable bowel syndrome, diabetes with depression, herpes vaccine, obesity, vaginal infection, prevention of bone Boynton says students unaware of oral sex dangers Minnesota Daily, MN - Oct 20, 2005 Oral sex is supposedly a way for people to experience sex without the risks of vaginal or anal The biggest risk for unprotected oral sex is herpes, Dorman said Indevus Announces Initiation of Phase III Trial of PRO 2000 Genetic Engineering News, NY - Oct 25, 2005 PRO 2000, the Company's topical, vaginal microbicide in development for the prevention of sexually transmitted infections, including HIV, herpes, chlamydia and Cervical cancer drkoop.com - Oct 25, 2005 are at risk of a rare form of cervical and vaginal cancer. Infections with genital herpes or chronic chlamydia infections, both sexually transmitted diseases
<< Home